Sorafenib Induces Delayed-Onset Cutaneous Hypersensitivity: A Case Series

Kyoung-Hee SOHN; Soo-Yeon OH; Kyung-Whan LIM; Mi-Yeong KIM; Suh-Young LEE; Hye-Ryun KANG.
Allergy, Asthma & Immunology Research ; : 304-307, 2015.
Artículo en Inglés | WPRIM | ID: wpr-85009

Documentos relacionados

  1. Erythema multiforme in children.
  2. Mycoplasma pneumoniae-induced rash and mucositis.
  3. Reactive infectious mucocutaneous eruption due to COVID-19 with erythema-multiforme-like lesions and myeloid cells.
  4. Desmoplakin I/II immunohistochemical staining may be a helpful tool in differentiating cutaneous graft versus host disease from the erythema multiforme, Stevens-Johnson syndrome, and toxic epidermal necrolysis spectrum disorders.
  5. Recent Updates in the Treatment of Erythema Multiforme.
  6. Childhood epidermal necrolysis and erythema multiforme major: a multicentre French cohort study of 62 patients.
  7. Erythema multiforme, Stevens-Johnson syndrome/toxic epidermal necrolysis - diagnosis and treatment.
  8. Oseltamivir induced oral-only erythema multiforme.
  9. Sintilimab-induced erythema multiforme drug eruption in the treatment of sigmoid colon cancer: A case report and literature review.
  10. Erythema multiforme associated with cancer radiotherapy: A single-institution case series and literature review.